$14.71
-1.34-8.35%
Last update: Nov 10, 4:00 PM
Carlsmed Inc
CARLNASDAQ
Carlsmed rose 27.3% from $12.61 to $16.05, ahead of the S&P 500's +10.0%. Its worst day was Dec 4 (−15.2%), and its low came Apr 29 at $8.83.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Carlsmed shares rose 11.2%, while the S&P 500 rose 1.5%.
+11.2% · S&P 500 +1.5%
Carlsmed closed at its highest level of the year, 34.7% above where the year started.
+4.4% · S&P 500 +0.1%
Story events cover the past 12 months · Times ET
Fourth quarter 2025 revenue of ~$15.2 million, representing ~61% growth over Q4 2024Full Year 2025 revenue of ~$50.5 million; representing ~86% growth over 2024CARLSBAD, Calif., Jan.
+13.8% · S&P 500 +0.2%
EPS of $-0.32 beat the $-0.43 estimate on $15.2M revenue (est. $14.9M); FY revenue guidance of $70.0M–$75.0M against the $69.5M consensus.
+15.9%, the year's best day · S&P 500 −0.6%
EPS of $-0.32 beat the $-0.40 estimate on $16.1M revenue (est. $14.9M); FY revenue guidance of $72.0M–$77.0M against the $72.5M consensus.
+10.3% · S&P 500 +1.4%
Carlsmed shares rose 12.8%, while the S&P 500 fell 0.1%.
+12.8% · S&P 500 −0.1%
EPS of $-0.39 missed the $-0.38 estimate on $18.9M revenue (est. $18.1M); FY revenue guidance of $74.0M–$78.0M against the $75.0M consensus.
+1.0% · S&P 500 −0.2%
Carlsmed shares rose 11.7%, while the S&P 500 rose 1.7%.
+11.7% · S&P 500 +1.7%
Where it ended: a close of $16.05 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 10, 2026 (EPS est. $-0.39, revenue est. $19.2M).
Nothing in the past 12 months.
All CARL dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CARL and SPY from Benzinga historical bars. Not investment advice.
